Show simple item record

dc.contributor.authorGarcía Domínguez, Laura 
dc.contributor.authorNavas Macho, Patricia 
dc.contributor.authorVerdugo Alonso, Miguel Ángel 
dc.contributor.authorArias González, Victor Benito 
dc.contributor.authorGómez, Laura E.
dc.date.accessioned2025-01-23T12:05:19Z
dc.date.available2025-01-23T12:05:19Z
dc.date.issued2022
dc.identifier.citationGarcía-Domínguez, L., Navas, P., Verdugo, M. Á., Arias, V. B., & Gómez, L. E. (2022). Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors. Journal of Applied Research in Intellectual Disabilities, 35(5), 1109-1118. https://doi.org/10.1111/JAR.12996es_ES
dc.identifier.issn1360-2322
dc.identifier.urihttp://hdl.handle.net/10366/162374
dc.description.abstract[EN] Background: Psychotropic medication is frequently administered to people with intellectual disability with mental health and/or behavioural problems, instead of other non-pharmacological interventions. This study describes the mental health and behavioural problems of people aging with intellectual disability, their psychotropic medication intake, and the factors contributing to a greater medication intake. Method: The sample consisted of 991 people with intellectual disability over 45 years. Descriptive statistics and multinominal logistic regression were carried out. Results: Antipsychotics were the most used psychotropic drug. Older people with mild intellectual disability living in institutions and affected by mental health and behavioural problems were more likely to take larger amounts of psychotropic medication. Conclusions: Antipsychotics continue to be widely used by people with intellectual disability and mental and behavioural health problems, especially those in institutionalised settings. Future research should consider if medication intake could be reduced providing better supports in the community and non-pharmacological interventions.es_ES
dc.format.mimetypeapplication/pdf
dc.language.isoenges_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectaginges_ES
dc.subjectbehavioural problemses_ES
dc.subjectintellectual disabilityes_ES
dc.subjectmental healthes_ES
dc.subjectpsychotropic medicationes_ES
dc.titlePsychotropic drugs intake in people aging with intellectual disability: Prevalence and predictorses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.identifier.doi10.1111/JAR.12996
dc.relation.projectIDPSI2015-64517-Res_ES
dc.relation.projectID463AB012016es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.essn1468-3148
dc.journal.titleJournal of Applied Research in Intellectual Disabilitieses_ES
dc.volume.number35es_ES
dc.issue.number5es_ES
dc.page.initial1109es_ES
dc.page.final1118es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional